These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Psoriasis exacerbation after COVID-19 vaccination in high-risk group: How to manage it? Kabbani M; Poskin M; Benhadou F Dermatol Ther; 2022 May; 35(5):e15368. PubMed ID: 35141998 [No Abstract] [Full Text] [Related]
7. Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases. Shakoei S; Kalantari Y; Nasimi M; Tootoonchi N; Ansari MS; Razavi Z; Etesami I Dermatol Ther; 2022 Aug; 35(8):e15651. PubMed ID: 35716105 [TBL] [Abstract][Full Text] [Related]
8. Coronavirus disease 2019 vaccination in patients with psoriasis: A position statement from India by SIG psoriasis (IADVL Academy). Parthasaradhi A; Ganguly S; Kar BR; Thomas J; Neema S; Tahiliani S; Sathishkumar D; Parasramani SG; Chalam KV; Komeravalli H Indian J Dermatol Venereol Leprol; 2022; 88(3):286-290. PubMed ID: 35434988 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada. Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis exacerbation after COVID-19 vaccines: A brief report of the reported cases. El-Qushayri AE; Nardone B Dermatol Ther; 2022 Dec; 35(12):e15900. PubMed ID: 36200490 [TBL] [Abstract][Full Text] [Related]
11. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045 [TBL] [Abstract][Full Text] [Related]
13. Exacerbation of psoriasis following vaccination with the Pfizer-BioNTech BTN162b2 mRNA COVID-19 vaccine during risankizumab treatment. Tsunoda K; Watabe D; Amano H J Dermatol; 2023 Feb; 50(2):e79-e80. PubMed ID: 35795974 [No Abstract] [Full Text] [Related]
14. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. Jarius S; Bieber N; Haas J; Wildemann B J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110 [TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976 [TBL] [Abstract][Full Text] [Related]
16. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572 [TBL] [Abstract][Full Text] [Related]
18. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study. Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F; PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992 [TBL] [Abstract][Full Text] [Related]
19. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study. Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517 [No Abstract] [Full Text] [Related]
20. Safety and immunogenicity of intradermal administration of fractional dose CoronaVac Chatsiricharoenkul S; Niyomnaitham S; Posen HJ; Toh ZQ; Licciardi PV; Wongprompitak P; Duangchinda T; Pakchotanon P; Chantima W; Chokephaibulkit K Front Immunol; 2022; 13():1010835. PubMed ID: 36268028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]